149 related articles for article (PubMed ID: 37057131)
1. CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer.
Hu P; Lei L; Wang Y; Tian X; Wei X; Jiang N; Liu L
Mediators Inflamm; 2023; 2023():1075265. PubMed ID: 37057131
[TBL] [Abstract][Full Text] [Related]
2. Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
Martín de la Fuente L; Malander S; Hartman L; Jönsson JM; Ebbesson A; Nilbert M; Måsbäck A; Hedenfalk I
Int J Gynecol Pathol; 2018 Mar; 37(2):101-109. PubMed ID: 28481779
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma.
Zhang H; Yuan J; Xiang Y; Liu Y
J Oncol; 2022; 2022():2099327. PubMed ID: 36284635
[TBL] [Abstract][Full Text] [Related]
4. An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.
Huang C; Cui H; Lang X; Zhao F
J Immunol Res; 2022; 2022():9912732. PubMed ID: 35795530
[TBL] [Abstract][Full Text] [Related]
5. Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.
Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
[TBL] [Abstract][Full Text] [Related]
6. RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer.
Liao C; Zhao YX; Han WD; Lai NY
J Immunol Res; 2022; 2022():7599098. PubMed ID: 35310605
[TBL] [Abstract][Full Text] [Related]
7. High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker and Associated with Immune Infiltration in Advanced Gastric Cancer Microenvironment.
Shen N; Zhu S; Zhang Z; Yong X
J Oncol; 2022; 2022():1463316. PubMed ID: 36276283
[TBL] [Abstract][Full Text] [Related]
8. E74-like factor 3 suppresses microRNA-485-5p transcription to trigger growth and metastasis of ovarian cancer cells with the involvement of CLDN4/Wnt/β-catenin axis.
Kuang L; Li L
Saudi J Biol Sci; 2021 Aug; 28(8):4137-4146. PubMed ID: 34354393
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
10. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
11. An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers.
Li QJ; Wu ZL; Wang J; Jiang J; Lin B
J Ovarian Res; 2023 Mar; 16(1):51. PubMed ID: 36907877
[TBL] [Abstract][Full Text] [Related]
12. Development of a five-gene signature as a novel prognostic marker in ovarian cancer.
Wang R; Ye XH; Zhao XL; Liu JL; Zhang CY
Neoplasma; 2019 May; 66(3):343-349. PubMed ID: 30569721
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
14. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
16. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.
Ding C; Yu Z; Li X; Zhu J; Dai M; He Q
Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365
[TBL] [Abstract][Full Text] [Related]
17. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
Xie B; Tan G; Ren J; Lu W; Pervaz S; Ren X; Otoo AA; Tang J; Li F; Wang Y; Wang M
Front Oncol; 2022; 12():830908. PubMed ID: 35299734
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
Diao B; Yang P
Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
[TBL] [Abstract][Full Text] [Related]
20. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
